Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Rehabil Oncol. 2017 Jan;35(1):38–45.

Table 3. Mean and SD of FMA for Control and Intervention Groups.

Baseline 10-12 Weeks 20-22 Weeks
FMA (0-5) Control Intervention Control Intervention Control Intervention
Pain 4.0 (1.3) 4.3 (1.2) 4.5 (1.2) 4.6 (1.3) 4.2 (1.2) 4.7 (0.6)
TUG time 0.5 (1.1) 0.2 (0.6) 0.7 (1.5) 0.4 (1.1) 0.5 (1.1) 0.6 (1.3)
TUG HR 4.1 (1.5) 4.7 (0.6) 4.1 (1.6) 4.1 (0.9) 4.3 (1.1) 4.0 (1.6)
TUG RPE 4.1 (1.6) 4.9 (0.5) 4.4 (1.4) 4.6 (0.7) 4.6 (0.9) 4.6 (0.7)
TUDS time 0.6 (1.4) 0.0 (0.0) 0.7 (1.5) 0.0 (0.0) 0.5 (1.1) 0.5 (1.2)
TUDS HR 2.4 (1.9) 2.8 (1.6) 2.4 (1.9) 2.3 (2.1) 2.8 (1.8) 2.7 (1.8)
TUDS RPE 3.1 (1.8) 3.9 (0.9) 3.0 (1.7) 3.3 (1.5) 3.0 (1.2) 3.4 (1.2)
Supports 1.4 (1.7) 0.8 (0.7) 1.5 (1.5) 0.8 (0.7) 2.0 (1.9) 2.1 (1.8)
Satisfaction 2.9 (1.2) 3.4 (0.9) 3.2 (1.2) 3.5 (0.5) 3.2 (0.9) 3.6 (0.9)
9MWR Distance 1.5 (1.7) 0.9 (0.9) 1.2 (1.0) 1.1 (0.9) 0.9 (1.0) 1.3 (1.1)
9MWR HR 2.5 (1.4) 2.3 (1.0) 1.8 (1.3) 2.0 (0.9) 2.3 (0.9) 2.6 (1.2)
9MWR RPE 2.4 (1.7) 2.3 (1.4) 1.9 (1.8) 2.1 (1.4) 1.8 (1.5) 2.2 (1.4)
9MWR PCI 0.9 (1.5) 0.3 (0.6) 0.7 (1.4) 0.5 (0.7) 0.3 (0.6) 0.5 (0.8)
Participation 1.3 (1.3) 2.0 (1.6) 1.6 (1.3) 2.9 (1.3) 2.3 (1.5) 3.1 (1.7)
FMA Total Score (0-70) 25.9 (16.0) 31.9 (5.0) 28.9 (14.6) 31.1 (6.8) 25.7 (13.7) 35.6 (10.3)